Drug Trial Radar · NCT03584529
Association Between Vitamin D and the Development of Uterine Fibroids
Last checked: Nov 19, 2026Latest source record: Sep 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
360
Planned (sponsor's estimate)
Start
Sep 15, 2018
Primary completion
Jan 1, 2021
Study completion Jul 1, 2021
Sponsor
- Lead sponsor
- Second Affiliated Hospital of Wenzhou Medical UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 12, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 35 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
the aim of this randomised clinical trial study is to evaluate whether supplementation with vitamin D could inhibit the growth of uterine fibroids in reproductive stage women.
Conditions
- Gynaecological Disease
- Vitamin D Deficiency
Interventions
Vitamin D 3Drug
Non-Vitamin D3 Drops group Patients in this group would take nothing.
Primary outcomes
What the sponsor says the trial is designed to measure.
- volume of the total fibroidsTime frame: two years after treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.